From: Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer
Clinical characteristic | Univariate analysis | Â | Multivariate analysis | Uni/Multi Prognostic | ||||
---|---|---|---|---|---|---|---|---|
p-value | HR | 95%CI | Â | p-value | HR | 95%CI | ||
Age(years) | < 0.0001 | 1.56 | 1.26–1.94 |  | 0.0089 | 1.44 | 1.10–1.90 | Poor/Poor |
TRPM2 | 0.0183 | 1.37 | 1.05–1.78 |  | 0.028 | 1.37 | 1.03–1.81 | Poor/Poor |
Grade | 0.168 | 1.23 | 0.92–1.64 |  | 0.7002 | 1.08 | 0.72–1.64 | -/- |
Race | 0.0986 | 0.81 | 0.63–1.04 |  | 0.0082 | 0.67 | 0.47–0.90 | -/Good |
TNM stage | 0.0008 | 1.43 | 1.16–1.76 |  | 0.0244 | 1.43 | 1.05–1.94 | Poor/Poor |